Bladder Cancer Trial, Recruiting NCT06337942 Sponsor: University of California, Los Angeles Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06337942
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old.
  • You have a serious bladder condition that has caused ongoing infections, poor bladder function, or damage to your kidneys and urinary tract.
  • You have had bladder cancer (confined to the bladder, not spread) that required full removal of the bladder, and you have been cancer-free for an appropriate period of time — and you would need both a kidney and bladder transplant, or you already have a transplanted organ.
  • You are already taking anti-rejection medication for a previously transplanted organ.
  • You are willing and able to follow the treatment plan required by this trial.
  • You have been fully vaccinated and boosted against COVID-19, or you are willing to get vaccinated before joining.
  • You (or someone helping you at home) are able to perform a clean catheter procedure to drain the bladder, and can demonstrate this skill before the transplant.
  • You do not have any other serious medical condition that the study team believes would make surgery too risky or affect the treatment plan.
  • You do not have active alcohol or drug misuse problems.
  • Your immune system does not react against the donor's tissue (called a "negative crossmatch").

Who may not be able to join:

  • You have HIV (active or have tested positive), active Hepatitis B or C, untreated severe infection (sepsis), active tuberculosis, or certain other active infections such as chickenpox-related virus or toxoplasmosis.
  • You have a blood clotting disorder such as hemophilia, Von Willebrand's disease, sickle cell disease, thalassemia, or similar inherited conditions that could increase surgical risks.
  • You have certain connective tissue or immune-related conditions that can affect wound healing, such as severe rheumatoid arthritis, Ehlers-Danlos syndrome, or certain nerve disorders (confirm with trial site).
  • You have a storage disease affecting the body's tissues that may interfere with nerve recovery after surgery (confirm with trial site).
  • You have poor liver function, including abnormal liver blood test results or related blood clotting problems.
  • You have severely low red blood cells, white blood cells, or platelets as measured by a blood test.
  • You are unwilling to get vaccinated against COVID-19 before the transplant.
  • You have had a cancer other than bladder cancer in the past 5 years (except for certain common skin cancers).
  • You have a history of cancer that has spread to other parts of the body.
  • You are unable to attend regular follow-up appointments or unable to take anti-rejection medication due to location, finances, or other reasons.
  • You are a current smoker and cannot show that you have stopped smoking for at least 6 months before being listed, or you are unwilling to stay smoke-free after surgery.
  • You have a documented history of not following medical advice, untreated psychological conditions, or substance misuse, or have not completed a psychological evaluation.
  • The trial's medical team decides, through a group review process, that you may not be ready or able to manage the demands of this type of transplant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 310-794-8893

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Demonstrating the technical success of bladder or combined kidney-bladder transplantation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov